Members from the state’s board of medicine and osteopathic medicine voted in favor of sending the controversial rule which would likely bar puberty blockers, hormone replacement therapy as well as surgical interventions, which are extremely rare, as a treatment for gender dysphoria in minors to the full boards on Nov. 4.